More than 600 cancer deaths in Ireland could be avoided each year if survival rates here matched those in the best-performing countries in western Europe, according to a new study.
This includes 230 potentially avoidable breast cancer deaths, 129 colon cancer deaths and 99 prostate cancer deaths.
[ Doctors in ‘race against time’ to identify missed cancer diagnosesOpens in new window ]
“Ireland appears to be a country where survival rates are comparatively low given the estimated level of health spending on cancer,” the study by the Swedish Institute for Health Economics notes, adding that “there seems to be room to improve patient outcomes with existing resources and thereby increase the added value for each additional euro spent”.
The most successful increase in survival rates has been with multiple myeloma, from 27 per cent in the 1990s to 64 per cent in 2014-18.
Ireland v Fiji player ratings: Bundee Aki bounces back, Caelan Doris leads by example
David McWilliams: The potential threats to Ireland now come in four guises
The album that nearly finished U2: The story of How to Dismantle an Atomic Bomb and its new ‘shadow’ LP
‘I know what happened in that room’: the full story of the Conor McGregor case
[ Winning the fight against cancer: ‘It’s just miraculous’Opens in new window ]
Yet for many other cancers, Ireland lags behind other western European countries for survival rates, the study says. It has, for example, the lowest survival rates for breast and ovarian cancer.
The use of modern cancer medicines in Ireland seemed to be “fairly close” to the EU-15 average, it found.
The Irish Pharmaceutical Healthcare Association, which commissioned the study, said Ireland lags behind its European neighbours in access to new medicines.
The number of cancer cases has doubled from about 12,000 a year in 1995 to about 24,000 in 2017-19. This figure is projected to reach 42,000 by 2040. The increase is largely due to demographic factors as the population ages.
